Brisbane, Aug 24, 2017 AEST (ABN Newswire) - Australian medical device company, Oventus Medical Ltd. (
ASX:OVN) is pleased to share Dr Chris Hart's interview on Financial News Network.
In the interview, Dr Hart discusses Oventus' three products cleared with the US FDA and the agreement with Modern Dental Group, the largest manufacturer and distributor of dental prosthetics in the world.
To view the interview, please click the link below:
http://www.abnnewswire.net/press/en/89683/ovn
About Oventus Medical Ltd
Oventus Medical Ltd (ASX:OVN) is a Brisbane based medical device company that is commercialising a unique treatment platform for the treatment of sleep apnoea and snoring. Unlike other oral appliances or CPAP interfaces, the Oventus devices have a unique and patented airway within the treatment platform that allows air to flow to the back of the mouth unobstructed while maintaining an oral seal and stable jaw position, bypassing multiple obstructions from the nose, soft palate and tongue, reducing airway collapsibility and managing mouth breathing while maintain a stable airway with or without nasal CPAP. They are particularly designed for the many people that have nasal obstructions and consequently tend to mainly breathe through their mouth. While it may seem counterintuitive, this technology actually manages mouth breathing by converting it to device breathing and normalising ventilation. The O2Vent(TM) is designed to allow nasal breathing when the nose is unobstructed, but when obstruction is present, breathing is supplemented via the airways in the appliance.
For more information on Oventus' Sleep Treatment Platform, please visit https://www.oventus.com
| ||
|
